"Cell Line, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cell line derived from cultured tumor cells.
| Descriptor ID |
D045744
|
| MeSH Number(s) |
A11.251.210.190 A11.251.860.180
|
| Concept/Terms |
Cell Line, Tumor- Cell Line, Tumor
- Cell Lines, Tumor
- Line, Tumor Cell
- Lines, Tumor Cell
- Tumor Cell Lines
- Tumor Cell Line
|
Below are MeSH descriptors whose meaning is more general than "Cell Line, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Cell Line, Tumor".
This graph shows the total number of publications written about "Cell Line, Tumor" by people in this website by year, and whether "Cell Line, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 9 | 9 |
| 2004 | 0 | 20 | 20 |
| 2005 | 1 | 22 | 23 |
| 2006 | 0 | 29 | 29 |
| 2007 | 0 | 28 | 28 |
| 2008 | 0 | 39 | 39 |
| 2009 | 0 | 53 | 53 |
| 2010 | 0 | 40 | 40 |
| 2011 | 0 | 52 | 52 |
| 2012 | 0 | 27 | 27 |
| 2013 | 0 | 54 | 54 |
| 2014 | 1 | 34 | 35 |
| 2015 | 0 | 54 | 54 |
| 2016 | 0 | 58 | 58 |
| 2017 | 1 | 46 | 47 |
| 2018 | 0 | 47 | 47 |
| 2019 | 0 | 50 | 50 |
| 2020 | 0 | 40 | 40 |
| 2021 | 0 | 36 | 36 |
| 2022 | 0 | 20 | 20 |
| 2023 | 0 | 9 | 9 |
| 2024 | 0 | 25 | 25 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Line, Tumor" by people in Profiles.
-
PARP12-mediated ADP-ribosylation contributes to breast cancer cell fate by regulating AKT activation and DNA-damage response. Cell Mol Life Sci. 2025 Jan 23; 82(1):58.
-
Targeting Oncogenic RET Kinase by Simultaneously Inhibiting Kinase Activity and Degrading the Protein. J Med Chem. 2025 Jan 09; 68(1):81-94.
-
Real-time viscoelastic deformability cytometry: High-throughput mechanical phenotyping of liquid and solid biopsies. Sci Adv. 2024 Dec 06; 10(49):eabj1133.
-
Oklahoma nitrone-007 is an effective anticancer therapeutic agent targeting inflammatory and immune metabolism pathways in endometrial cancer. J Pharmacol Exp Ther. 2025 Jan; 392(1):100004.
-
MetaPhenotype: A Transferable Meta-Learning Model for Single-Cell Mass Spectrometry-Based Cell Phenotype Prediction Using Limited Number of Cells. Anal Chem. 2024 Dec 10; 96(49):19238-19247.
-
NKX3-2 Induces Ovarian Cancer Cell Migration by HDAC6-Mediated Repositioning of Lysosomes and Inhibition of Autophagy. Cells. 2024 Nov 04; 13(21).
-
Targeting HSP70-E7 Interaction With SHetA2: A Novel Therapeutic Strategy for Cervical Cancer. J Med Virol. 2024 Nov; 96(11):e70088.
-
Localized ablative immunotherapy enhances antitumor immunity by modulating the transcriptome of tumor-infiltrating Gamma delta T cells. Cancer Lett. 2024 Nov 01; 604:217267.
-
Development of Novel Indole-Based Covalent Inhibitors of TEAD as Potential Antiliver Cancer Agents. J Med Chem. 2024 Sep 26; 67(18):16270-16295.
-
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient Samples. Cancer Res Commun. 2024 09 01; 4(9):2384-2398.